Psyence Biomedical Ltd. (PBM) Earnings History
Annual and quarterly earnings data from 2021 to 2023
Loading earnings history...
PBM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PBM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export PBM earnings history in CSV or JSON format
Free sign-in required to download data
Psyence Biomedical Ltd. (PBM) Earnings Overview
As of May 8, 2026, Psyence Biomedical Ltd. (PBM) reported trailing twelve-month net income of -$25M, reflecting -1126.6% year-over-year growth. The company earned $-1.90 per diluted share over the past four quarters.
Looking at the long-term picture, PBM's historical earnings data spans multiple years. The company achieved its highest annual net income of $8M in fiscal 2021.
Psyence Biomedical Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPS (-$288M net income), MNMD (-$238M net income), ATAI (-$154M net income, -48464.0% margin), PBM has comparable earnings metrics. Compare PBM vs CMPS →
PBM Earnings vs Peers
Earnings metrics vs comparable public companies
PBM Historical Earnings Data (2021–2023)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2023 | -$51M | -738.3% | -$3M | $-7.85 | - | - |
| 2022 | $8M | -2.6% | -$1M | $-0.64 | - | - |
| 2021 | $8M | - | $-334,290 | $0.25 | - | - |
See PBM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PBM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PBM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPBM — Frequently Asked Questions
Quick answers to the most common questions about buying PBM stock.
Is PBM growing earnings?
PBM EPS fell to $-1.90, with earnings declining -1126.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-25M.
What are PBM's profit margins?
Psyence Biomedical Ltd. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are PBM's earnings?
PBM earnings data spans 2021-2023. The declining earnings trend is -1126.6% YoY. Historical data enables comparison across business cycles.